HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
89.22
-0.97 (-1.08%)
Mar 26, 2025, 4:00 PM EST - Market closed
HealthEquity Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for HealthEquity stock have an average target of 113.31, with a low estimate of 103 and a high estimate of 130. The average target predicts an increase of 27.00% from the current stock price of 89.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 8 | 8 | 9 | 9 | 9 | 8 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy → Strong Buy Upgrades $120 → $115 | Buy → Strong Buy | Upgrades | $120 → $115 | +28.89% | Mar 25, 2025 |
| Keybanc | Keybanc | Buy Maintains $120 → $110 | Buy | Maintains | $120 → $110 | +23.29% | Mar 24, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $112 | Buy | Maintains | $112 | +25.53% | Mar 19, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $112 | Buy | Maintains | $112 | +25.53% | Mar 14, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $110 → $125 | Buy | Maintains | $110 → $125 | +40.10% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
1.31B
from 1.20B
Increased by 9.35%
Revenue Next Year
1.45B
from 1.31B
Increased by 10.29%
EPS This Year
3.75
from 1.09
Increased by 243.94%
EPS Next Year
4.55
from 3.75
Increased by 21.31%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.6B | 1.8B |
| Avg | 1.3B | 1.4B | 1.7B |
| Low | 1.3B | 1.4B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.4% | 18.8% | 25.3% |
| Avg | 9.4% | 10.3% | 16.6% |
| Low | 4.7% | 3.6% | 9.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.18 | 5.03 | 5.72 |
| Avg | 3.75 | 4.55 | 5.50 |
| Low | 3.53 | 4.23 | 5.34 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 283.4% | 34.2% | 25.8% |
| Avg | 243.9% | 21.3% | 21.0% |
| Low | 223.7% | 12.9% | 17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.